| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| enGene Holdings Inc. | Chief Medical Officer | Stock Option (Right to Buy) | 280,000 | 29 Jan 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ENGN | enGene Holdings Inc. | 29 Jan 2025 | 1 | $0 | 4 | Chief Medical Officer | 31 Jan 2025, 16:46 |
| ENGN | enGene Holdings Inc. | 24 Jul 2024 | 1 | $0 | 4 | Chief Medical Officer | 25 Jul 2024, 20:32 |
| ENGN | enGene Holdings Inc. | 22 Jul 2024 | 0 | $0 | 3 | Chief Medical Officer | 25 Jul 2024, 20:30 |